Article Data

  • Views 336
  • Dowloads 149

Meeting Abstracts

Open Access

Regional Anaesthesia: Key component analgesia in multimodal personalized postoperative pain management

  • Dimitra Morella1

1Department of Anesthesiology-Pain Clinic, “KAT” General Hospital of Athens, Athens, Greece

DOI: 10.22514/sv.2021.190 Vol.17,Issue S1,September 2021 pp.45-45

Submitted: 26 August 2021 Accepted: 06 September 2021

Published: 15 September 2021

*Corresponding Author(s): Dimitra Morella E-mail: morella0382@gmail.com

Abstract

The benefits of multimodal analgesia as a way of managing perioperative pain are well evidenced. The synergic effect maximizes pain relief at lower analgetic doses, thereby reduces the risk of adverse drug effect. But despite the progress in non-opioid analgesics and multimodal pain regiments they still can’t achieve significant pain alleviation on their own.

Therefore regional anesthesia plays a crucial role in multimodal plan providing enhancement to perioperative pain management.

But which is the most appropriate regional technique to choose and what skills and infrastructure are required for its implementation?

A personalized approach will define the right pathway for achieving balanced and effective perioperative pain management. Incorporating factors specific to the patient (sex, comorbidities etc.) the intended surgery (surgical approach etc) and the resources available in the institutducation of ward staff, ultrasound device etc) we can structure the suitable multimodal plan.


Cite and Share

Dimitra Morella. Regional Anaesthesia: Key component analgesia in multimodal personalized postoperative pain management . Signa Vitae. 2021. 17(S1);45-45.

References

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.

IndexCopernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.

Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.

Scopus: CiteScore 0.5(2019) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.

Submission Turnaround Time

Conferences

Top